Life Science Leader Chief Editor Blog Header image Life Science Leader Chief Editor Blog Header image

What Surprised Me — And Didn’t — At J.P. Morgan 2016
What Surprised Me — And Didn’t — At J.P. Morgan 2016 Unfortunately, a minor mechanical issue involving one of my flights caused me to arrive a day late for the 34th Annual J.P. Morgan Healthcare Conference (JPM) in San Francisco (January 11-14). While missing Monday at one of biopharma’s biggest annual events (Twitter hashtag #JPM16) translates to a huge lost opportunity (i.e., not being able to attend 16 of 108 scheduled presentations/breakout sessions), when it comes to JPM, one day does...  Continue Reading...
What Is Going To Be The Next Big Thing For Biopharma In 2016?
What Is Going To Be The Next Big Thing For Biopharma In 2016? There are plenty of industry insights available, such as Life Science Leader’s comprehensive December 2015 Outlook issue for 2016 or our four-part trendsetter series. And while these provide a wealth of insight, I felt compelled to put together one last blog to prevent you from being blindsided by the “Next Big Thing” in biopharma in 2016.  Continue Reading...
What Guides Your Company?
What Guides Your Company? If you have ever seen an employee of Johnson and Johnson speak, you probably recall that at some point during their presentation they probably made reference to “Our Credo” — a J&J document that describes the values used to guide employee decision making. “Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.” Written in 1943 by Robert Wood Johnson, former chairman and ...  Continue Reading...
The Folly Of Burying Great Insight
The Folly Of Burying Great Insight Last week I posted “Why The Wall Street Journal’s U.S. Drug Price Comparison Misses The Mark,” a criticism of health and science deputy bureau chief Jeanne Whalen’s Dec. 1, 2015 article titled, “U.S. Drug Prices Dwarf Other Nations.” What bothered me about this article was that I felt it skewed the facts, sensationalized the issue, and seemed intent on stirring up controversy.  Continue Reading...
FDA/CMS Summit Demonstrates Need For Innovative Hiring Solutions
FDA/CMS Summit Demonstrates Need For Innovative Hiring Solutions When Janet Woodcock, M.D., kicked of this year’s FDA/CMS Summit for biopharmaceutical executives, the FDA’s director for the Center for Drug Evaluation & Research (CDER) did so by recapping what was achieved in 2015, as well as sharing her lengthy list of priorities for the coming year. According to Woodcock, the challenge to successful implementation of various priorities is analogous to keeping an airplane flying while at the...  Continue Reading...
Why The <em>Wall Street Journal’s</em> U.S. Drug Price Comparison Misses The Mark
Why The Wall Street Journal’s U.S. Drug Price Comparison Misses The Mark In the December 1, 2015 edition of the Wall Street Journal there is an article titled, “U.S. Drug Prices Dwarf Other Nations.” The author, health and science deputy bureau chief Jeanne Whalen, begins by pointing out that Norway, an oil producer with one of the richest economies in the world, is an expensive place to live. To support her claim she highlights Norway’s cost of a Big Mac ($5.65) and a gallon of gasoline ($6). But...  Continue Reading...
There’s More To January Than Just the JPM Conference
There’s More To January Than Just the JPM Conference One of the biggest biopharmaceutical industry events, the 34th Annual JP Morgan Healthcare Conference, is right around the corner, January 11-14. And while the event is famous for overrunning San Francisco with neckties, as well as blowing up Twitter with its hashtag #JPM2016, there are a number of other worthwhile events also taking place. For example, just down the street is the 8th Annual Biotech Showcase #BTS2016. In fact, last year my...  Continue Reading...
ISPE Meeting Provides Emotional Rollercoaster
ISPE Meeting Provides Emotional Rollercoaster Stepping out of my hotel room on the last day of the 2015 International Society of Pharmaceutical Engineering (ISPE) annual meeting in Philadelphia (November 8 – 11), I reach down and pick up the USA Today that is blocking my egress. Flipping through the newspaper the headline “Allen Always Aimed High” catches my eye. As writer Nicole Auerbach relates how Duke University basketball standout Grayson Allen strived to achieve his...  Continue Reading...
How Can You Provide Healthcare Value In A Patient-Centric Era?
How Can You Provide Healthcare Value In A Patient-Centric Era? Patients have become more empowered, better informed, and more financially invested in their health and well-being than ever before. As a result, we have seen the healthcare landscape evolve toward a patient-centric delivery model.  Continue Reading...
Does Being Disruptively Innovative Translate Into Being More Patient-Centric?
Does Being Disruptively Innovative Translate Into Being More Patient-Centric? Everyone has experienced poor customer service in one form or another. Say you want to call a company with a question or a complaint about a product. You’re likely to be informed by an automated voice that, “Due to the high volume of calls we are currently experiencing, your anticipated wait time will be X minutes.  For faster and more convenient customer service, please visit our website at www.wedon’tcaretospeaktoyou...  Continue Reading...